During the past decade, Ch Valenciennes conducted 90 clinical trials. In the 10-year time frame, 90 clinical trials started and 4 clinical trials were completed, i.e. on average, 4.4% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 4 clinical trials were completed. i.e. 9.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ch Valenciennes" #1 sponsor was "University Hospital, Lille" with 26 trials, followed by "Centre Oscar Lambret" with 9 trials sponsored, "The Lymphoma Academic Research Organisation" with 7 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 6 trials sponsored and "Acute Leukemia French Association" with 6 trials sponsored. Other sponsors include 83 different institutions and companies that sponsored additional 70 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ch Valenciennes" #1 collaborator was "Ministry of Health, France" with 10 trials as a collaborator, "Région Nord-Pas de Calais, France" with 5 trials as a collaborator, "National Cancer Institute, France" with 3 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator and "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator. Other collaborators include 109 different institutions and companies that were collaborators in the rest 113 trials.

According to Clinical.Site data, the most researched conditions in "Ch Valenciennes" are "Breast Cancer" (7 trials), "Acute Myeloid Leukemia" (5 trials), "Critical Illness" (4 trials), "Alcoholic Hepatitis" (3 trials) and "Atrial Fibrillation" (3 trials). Many other conditions were trialed in "Ch Valenciennes" in a lesser frequency.

Most popular intervention types in "Ch Valenciennes" are "Drug" (61 trials), "Other" (29 trials), "Device" (16 trials), "Procedure" (13 trials) and "Behavioral" (10 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Apixaban" (3 trials), "Doxorubicin" (3 trials), "Prednisone" (3 trials) and "fluorouracil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ch Valenciennes" are 130 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Ch Valenciennes". 1 are not yet recruiting, 36 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 69 completed trials in Ch Valenciennes, 1 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Ch Valenciennes, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 41 trials that are defined as “Not Applicable".